| [1] |
Boskovic A, Kitic I, Prokic D, et al. Sample representativeness and incidence of liver biopsy complications caused by needles of bigger diameter (1.6 mm) and smaller diameter (1.2 mm) in children with cholestatic syndrome[J]. Med Pregyl, 2013(66):367-371.
|
| [2] |
Kose S, Ersan G, Tatar B, et al. Evaluation of percutaneous liver biopsy complications in patients with chronic viral hepatitis[J].Eurasian J Med, 2015(47):161-164．
|
| [3] |
Bhardwaj N, Strickland AD, Ahmad F, et al. Liver ablation techniques: a review[J]. Surg Endesc, 2010, 24(2):254-265.
|
| [4] |
Ng KK, Poon RT, Lam CM, et al. Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusion[J]. Br J Surg, 2006, 93(4):440-447.
|
| [5] |
Kotoh K, Morizono S, Kohjima M, et al. Evaluation of liver parenchymal pressure and portal endothelium damage during radio frequency ablation in an in vivo porcine model[J]. Liver Int, 2005, 25(6):1217-1223.
|
| [6] |
DeWitt J, LeBlanc J, McHenry L, et a1. Endoscopic ultrasound-guided fine needle aspiration cytology of solid liver lesions:a large single-center experience[J]. Am J Gastroenterol, 2003, 98(9):1976-1981．
|
| [7] |
王艳苓，张红红，王秀燕．超声引导下经皮肝脏穿刺活检的临床价值[J]．实用肝脏病杂志，2009,12(1):52-54.
|
| [8] |
李凯，许尔蛟，郑荣琴，等．融合成像超声造影术中即时评估肝癌射频消融疗效[J]．中华超声影像学杂志，2013,22(7):587-590.
|
| [9] |
徐建红，王知力，汪伟安，等．超声造影在肝占位性病变穿刺活检中的应用价值[J]．中华超声医学杂志，2010,26(10):922-924.
|
| [10] |
Von Herbay A, Westendorff J, Gregor M. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients[J]. J Clin Ultrasound, 2010, 38(1):1-9.
|
| [11] |
Cho YK, Kim Y, Rhim H. Pitfalls in the radiological and pathological correlation of tumour response rates of hepatocellular carcinoma following radiofrequency ablation[J]. J Clin Pathol, 2009, 62(12):1071-1073.
|
| [12] |
Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series[J]. Eur Radiol, 2007(17):684-692.
|
| [13] |
Morimoto M, Sugimori K, Shimto K，et al．Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods[J]．Hepatology, 2002, 35(6):S146-147．
|
| [14] |
Ikemoto T, Shimada M, Yamada S. Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation[J]. Hepatol Res, 2017, 47(1):23-30.
|
| [15] |
Kalogeridi MA, Zygogianni A, Kyrgias G, et al. Role of radiotherapy in the management of hepatocelluelar carcinoma: a systematic review[J]. World J Hepatol, 2015, 7(1):101-112.
|
| [16] |
Yoshida S, Kornek M, Ikenaga N, et al. Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma[J]. Hepatology, 2013(58):1667-1680.
|
| [17] |
Poggi G, Tosoratti N, Montagna B, et al. Microwave ablation of hepatocellular carcinoma[J]. World J Hepatol, 2015(7):2578-2589.
|
| [18] |
Nishikawa H, Osaki Y, Iguchi E, et al. Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes[J]. J Gastroenterol, 2013, 48(8):951-965.
|
| [19] |
Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64(1):73-84.
|
| [20] |
Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update[J]. Hepatol Int, 2017, 11(4):317-370.
|